prostate cancer

Search

19.1.2024

Contour+ performance on Male Pelvis synthetic CTs

Results of MVision AI’s solutions scientific evaluation were presented at the previous ASTRO annual meeting. One of the posters included data from paired MRI and synthetic CT scans (MRCAT) of male pelvis and showed the accuracy and consistency of Contour+ models. The abstract was published in  Volume 117 Issue 2…

Articles

9.1.2023

NCCC Evaluation of MVision AI contouring software

S Warren, N Richmond MVision AI software has been under evaluation at NCCC (Newcastle upon Tyne Hospitals NHS Foundation Trust) since 28 February 2022* in order to: 1. compare AI contour quality and consistency with manual contouring; 2. estimate potential improvements in efficiency; 3. identify opportunities to improve clinical workflow.…

Articles

17.6.2022

RT for Prostate Cancer: Faster and Better – Is it Possible?

Background Worldwide, more than 1 400 000 men were diagnosed with prostate cancer in 2020, and it is estimated that one third will need radiotherapy during their treatment. (more…)

Articles

26.8.2021

What is the Current State of Cancer Care in Spain?

The cancer rates in Spain are rather unsettling. In 2020 alone, there were well over 282,000 new cancer cases and over 113,000 cancer deaths. Currently, the five most common types of cancer that have devastated the Spanish population overall are:  (more…)

News

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI